The APHINITY Trial
APHINITY Trial in HER2+ Breast Cancer
APHINITY Trial for HER2+ Breast Cancer
Dr. Han on the APHINITY Trial in HER2+ Early-Stage Breast Cancer
APHINITY Trial: Adjuvant Pertuzumab and Trastuzumab
SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02
The APHINITY debate: should we change our treatment of breast cancer?
The APHINITY Trial in Early-Stage HER2+ Breast Cancer
Cardiac safety in the APHINITY study
APHINITY: 6-year follow-up results of dual HER2 blockade in HER2+ breast cancer
Dr. Crew on the APHINITY Trial Results in HER2+ Breast Cancer
Dr. Gorantla Addresses Unanswered Questions From the APHINITY Trial
Aphinity - Echo:Starlight
APHINITY: Adding pertuzumab to trastuzumab plus chemotherapy in patients with operable HER2-posi...
Dr. Jahanzeb on the APHINITY and ExteNET Trials in Breast Cancer
Interim overall survival analysis of APHINITY (BIG 4-11
Resultados do estudo APHINITY
Dr. Yardley on the APHINITY Trial for HER2-Positive Breast Cancer
The APHINITY Trial Regimen Efficacy & Toxicity Profile
APHINITY study